Curriculum Vitae
Shinya UCHIDA, Ph.D.
Professor,
Department of Pharmacy Practice and Science, School of Pharmaceutical Sciences, University ofShizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan
E-mail: uchidas@u-shizuoka-ken.ac.jp
Education
B.Sc. in Pharmacy, School of Pharmaceutical Sciences, University of Shizuoka, 1993
M.Sc. in Pharmacy, School of Pharmaceutical Sciences, University of Shizuoka, 1995
Ph.D. in Pharmacy, School of Pharmaceutical Sciences, University of Shizuoka, 1998
Work Experience
1998–2003
Clinical Pharmacist; Hospital Pharmacy, Hamamatsu University School ofMedicine, University Hospital
2003–2005

Research Assistant Professor; Department of Clinical Pharmacology &Therapeutics, Hamamatsu University School of Medicine

2003–2005

Research Assistant Professor; Center for Clinical Research, Hamamatsu
University School of Medicine, University Hospital
Assistant Professor; Department of Biopharmacy (Pharmacokinetics &Pharmacodynamics), School of Pharmaceutical Sciences, University ofShizuoka

2005–2008

2008–2011

Assistant Professor; Department of Pharmacy Practice & Science, School of
Pharmaceutical Sciences, University of Shizuoka

2008
2011–2021

Visiting Scalar; Collage of Pharmacy, University of Arizona
Associate Professor; Department of Pharmacy Practice and Science, School of
Pharmaceutical Sciences, University of Shizuoka2021–present

Professor; Department of Pharmacy Practice and Science, School of
Pharmaceutical Sciences, University of Shizuoka

Awards2004 IUPHAR Young Investigator Award (Gold Award), 8th World Conference on ClinicalPharmacology Therapeutics
Recent publications
1.

Shimako Tanaka, Shinya Uchida, Akio Hakamata, Sachiko Miyakawa, Keiichi Odagiri,Naoki Inui, Hiroshi Watanabe, Noriyuki Namiki: Simultaneous LC-MS Analysis of Plasma
Concentrations of Sildenafil, Tadalafil, Bosentan, Ambrisentan, and Macitentan in Patientswith Pulmonary Arterial Hypertension. Pharmazie, 75, 236-239 (2020)

2.

Homare Kurashima, Shinya Uchida, Yasuharu Kashiwagura, Shimako Tanaka, Noriyuki
Namiki: Evaluation of Weight Variation in Mini-Tablets Manufactured by a Multiple-TipTool. Chem Pharm Bul, 68, 981-988 (2020)

3.

Shimako Tanaka, Shinya Uchida, Mai Sotoyama, Yasuharu Kashiwagura, Noriyuki Namiki:
Combining Powder Formulations of Drugs with Food and Beverages to Improve Palatability.
Biol Pharm Bull., 43, 1954-1959 (2020)

4.

Imai H, Morita M, Morita H, Ohyama T, Tanaka S, Uchida S, Namiki N, Uemura N, Ohashi
K: The μ-opioid receptor gene polymorphism 118A>G weakens the pharmacological actionof buprenorphine. Int J Clin Pharmacol Ther, 58, 626-633 (2020)

5.

Takashi K Ito, Tomihito Sato, Akio Hakamata , Yuki Onoda, Shumpei Sato, Fumiyoshi
Yamazaki, Makoto Horikawa, Yutaka Takahashi, Takuya Kitamoto, Masako Suzuki, Shinya
Uchida, Keiishi Odagiri, Mitsutoshi Setou: A nonrandomized study of single oral
supplementation within the daily tolerable upper level of nicotinamide affects blood
nicotinamide and NADþ levels in healthy subjects. Trans. Med. Aging., 4, 45-54 (2020)

6.

Hidehito Takano, Shinya Uchida, Yasuharu Kashiwagura, Shimako Tanaka, Akio Hakamata,Keiichi Odagiri, Naoki Inui, Hiroshi Watanabe, Noriyuki Namiki: Preparation of Cocoa
Powder-Containing Orally Disintegrating Tablets of Rebamipide (Rebamipide Chocolet) andEvaluation of Their Clinical Palatability. Chem Pharm Bull, 67, 112-119 (2019)

7.

Mai Sotoyama, Shinya Uchida, Chiaki Kamiya, Shimako Tanaka, Yasuharu Kashiwagura,Akio Hakamata, Keiichi Odagiri, Naoki Inui, Hiroshi Watanabe, Noriyuki Namiki: Ease ofTaking and Palatability of Fixed-Dose Orally Disintegrating Mitiglinide/Voglibose Tablets.
Chem Pharm Bull, 67, 540–545 (2019)8.

Chiaki Kamiya, Naoki Inui, Akio Hakamata, Sachiko Miyakawa, Shimako Tanaka, ShinyaUchida, Noriyuki Namiki, Keiichi Odagiri, Hiroshi Watanabe: Effect of co-administeredinducer or inhibitor on omeprazole pharmacokinetics based on CYP2C19 genotype. J
Pharmacol Sci., 139, 361-366 (2019)9.

Mitsunobu Yoshida, Shinya Uchida, Yasuharu Kashiwagura, Shimako Tanaka, Rakan Matsui,Noriyuki Namiki: Evaluation of in Vitro and in Vivo Transdermal Absorption of Solifenacin
Succinate. Chem Pharm Bull, 67, 1225-1231 (2019)

10. Motoyasu Miura, Shinya Uchida, Shimako Tanaka, Naoki Inui, Junichi Kawakami J, Hiroshi
Watanabe, Noriyuki Namiki: The Prediction of the Area under the Curve and Clearance ofMidazolam from Single-Point Plasma Concentration and Urinary Excretion in Healthy
Volunteers. Biol Pharm Bull, 67, 1225-1231 (2019)11. Norimichi Akiyama, Naoki Inui, Kazutaka Mori, Yutaro Nakamura, Hiroshi Hayakawa,Shimako Tanaka, Shinya Uchida, Noriyuki Namiki, Hiroshi Watanabe, Takafumi Suda:
Effect of rifampicin and clarithromycin on the CYP3A activity in patients withMycobacterium avium complex. J Thorac Dis., 11, 3814–3821 (2019)12. Tsuyoshi Katayama, Shinya Uchida, Chiaki Kamiya, Shimako Tanaka, Yasuharu
Kashiwagura, Akio Hakamata, Keiichi Odagiri, Naoki Inui, Hiroshi Watanabe, Noriyuki
Namiki: In vivo drug dissolution in human oral cavity from orally disintegrating tablet andcomparability with in vitro testing. Chem Pharm Bull, 66, 999-1005 （2018）
13. Fumiaki Nakagaki, Shinya Uchida, Shimako Tanaka, Noriyuki Namiki: Palatability andpreference of gummi formulations with various pharmaceutical characteristics. Chem PharmBull, 66, 452-457 （2018）
14. Osamu Yasumuro, Shinya Uchida, Yasuharu Kashiwagura, Ayae Suzuki, Shimako Tanaka,
Naoki Inui, Hiroshi Watanabe, Noriyuki Namiki: Changes in gefitinib, erlotinib andosimertinib pharmacokinetics under various gastric pH levels following oral administration ofomeprazole and vonoprazan in rats. Xenobiotica, 48, 1106-1112 （2018）